Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385864002> ?p ?o ?g. }
- W4385864002 endingPage "e001328" @default.
- W4385864002 startingPage "e001328" @default.
- W4385864002 abstract "To analyse long-term outcomes of antivascular endothelial growth factor (anti-VEGF) therapy for the treatment of neovascular age-related macular degeneration (nAMD) using pro re nata (PRN) regimen in a single-centre clinical practice.All patients receiving intravitreal injection (IVI) for nAMD between 1 January 2008 and 31 December 2020 were searched from electronic medical records. All 3844 treatment-naïve eyes of 3008 patients were included with a total of 50 146 IVIs (87% bevacizumab) administered. Main outcome measures were mean change in visual acuity (VA) from baseline, proportion of eyes within 15 letters of baseline, proportion of eyes with VA ≥20/40 Snellen and ≤20/200 Snellen, number of annual visits and number of annual IVIs.The mean baseline VA was 55 Early Treatment Diabetic Retinopathy Study (ETDRS) letters and the mean change in VA from baseline was +2, +2, ±0, -2, -2 and -4 ETDRS letters at year 1, 2, 3, 5, 7 and 10, respectively. Proportions of eyes within 15 letters of baseline were 88%, 87%, 82%, 80%, 76% and 72% at the end of years 1, 2, 3, 5, 7 and 10, respectively. The median number of annual IVI was 6 at years 1-7 and 5 at year 10. The median number of annual total visits was 10 at year 1, 9 at years 2-7 and 8 at year 10, respectively.VA was maintained short-term and long-term with anti-VEGF therapy using PRN treatment regimen." @default.
- W4385864002 created "2023-08-17" @default.
- W4385864002 creator A5016776091 @default.
- W4385864002 creator A5016787872 @default.
- W4385864002 creator A5026197608 @default.
- W4385864002 creator A5027622578 @default.
- W4385864002 creator A5034244919 @default.
- W4385864002 creator A5043290195 @default.
- W4385864002 creator A5044882358 @default.
- W4385864002 creator A5079960489 @default.
- W4385864002 creator A5092647357 @default.
- W4385864002 date "2023-08-01" @default.
- W4385864002 modified "2023-09-25" @default.
- W4385864002 title "Ten-year real-world outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration using pro re nata regimen" @default.
- W4385864002 cites W1500728559 @default.
- W4385864002 cites W2004117352 @default.
- W4385864002 cites W2005009598 @default.
- W4385864002 cites W2020482183 @default.
- W4385864002 cites W2083043469 @default.
- W4385864002 cites W2085712747 @default.
- W4385864002 cites W2102946567 @default.
- W4385864002 cites W2124415048 @default.
- W4385864002 cites W2134161293 @default.
- W4385864002 cites W2140181275 @default.
- W4385864002 cites W2188489962 @default.
- W4385864002 cites W2265083335 @default.
- W4385864002 cites W2319705424 @default.
- W4385864002 cites W2344537514 @default.
- W4385864002 cites W2462291236 @default.
- W4385864002 cites W2466967895 @default.
- W4385864002 cites W2519403553 @default.
- W4385864002 cites W2586954607 @default.
- W4385864002 cites W2610506892 @default.
- W4385864002 cites W2732585901 @default.
- W4385864002 cites W2747836769 @default.
- W4385864002 cites W2754502683 @default.
- W4385864002 cites W2782057573 @default.
- W4385864002 cites W2789226077 @default.
- W4385864002 cites W2913259315 @default.
- W4385864002 cites W2952632634 @default.
- W4385864002 cites W2959321041 @default.
- W4385864002 cites W2979467486 @default.
- W4385864002 cites W2990343807 @default.
- W4385864002 cites W3002562981 @default.
- W4385864002 cites W3007579267 @default.
- W4385864002 cites W3012000803 @default.
- W4385864002 cites W3014487234 @default.
- W4385864002 cites W3029640339 @default.
- W4385864002 cites W3177777273 @default.
- W4385864002 cites W4214926418 @default.
- W4385864002 cites W4293456617 @default.
- W4385864002 cites W633153563 @default.
- W4385864002 doi "https://doi.org/10.1136/bmjophth-2023-001328" @default.
- W4385864002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37586826" @default.
- W4385864002 hasPublicationYear "2023" @default.
- W4385864002 type Work @default.
- W4385864002 citedByCount "0" @default.
- W4385864002 crossrefType "journal-article" @default.
- W4385864002 hasAuthorship W4385864002A5016776091 @default.
- W4385864002 hasAuthorship W4385864002A5016787872 @default.
- W4385864002 hasAuthorship W4385864002A5026197608 @default.
- W4385864002 hasAuthorship W4385864002A5027622578 @default.
- W4385864002 hasAuthorship W4385864002A5034244919 @default.
- W4385864002 hasAuthorship W4385864002A5043290195 @default.
- W4385864002 hasAuthorship W4385864002A5044882358 @default.
- W4385864002 hasAuthorship W4385864002A5079960489 @default.
- W4385864002 hasAuthorship W4385864002A5092647357 @default.
- W4385864002 hasBestOaLocation W43858640021 @default.
- W4385864002 hasConcept C118487528 @default.
- W4385864002 hasConcept C119767625 @default.
- W4385864002 hasConcept C134018914 @default.
- W4385864002 hasConcept C141071460 @default.
- W4385864002 hasConcept C2776403814 @default.
- W4385864002 hasConcept C2776694085 @default.
- W4385864002 hasConcept C2777802072 @default.
- W4385864002 hasConcept C2778257484 @default.
- W4385864002 hasConcept C2778749236 @default.
- W4385864002 hasConcept C2779829184 @default.
- W4385864002 hasConcept C2780699112 @default.
- W4385864002 hasConcept C2781100027 @default.
- W4385864002 hasConcept C2781413609 @default.
- W4385864002 hasConcept C555293320 @default.
- W4385864002 hasConcept C71924100 @default.
- W4385864002 hasConceptScore W4385864002C118487528 @default.
- W4385864002 hasConceptScore W4385864002C119767625 @default.
- W4385864002 hasConceptScore W4385864002C134018914 @default.
- W4385864002 hasConceptScore W4385864002C141071460 @default.
- W4385864002 hasConceptScore W4385864002C2776403814 @default.
- W4385864002 hasConceptScore W4385864002C2776694085 @default.
- W4385864002 hasConceptScore W4385864002C2777802072 @default.
- W4385864002 hasConceptScore W4385864002C2778257484 @default.
- W4385864002 hasConceptScore W4385864002C2778749236 @default.
- W4385864002 hasConceptScore W4385864002C2779829184 @default.
- W4385864002 hasConceptScore W4385864002C2780699112 @default.
- W4385864002 hasConceptScore W4385864002C2781100027 @default.
- W4385864002 hasConceptScore W4385864002C2781413609 @default.
- W4385864002 hasConceptScore W4385864002C555293320 @default.
- W4385864002 hasConceptScore W4385864002C71924100 @default.